Skip to main content
Top
Published in: Rheumatology International 5/2022

01-05-2022 | Arthritis | Observational Research

Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey

Authors: Tobias Eschricht Eriksen, Wilfred K. H. Dinesen, Line Uhrenholt, Lene Dreyer, Kirsten Duch, Salome Kristensen

Published in: Rheumatology International | Issue 5/2022

Login to get access

Abstract

As a result of the pandemic, many patients with an inflammatory rheumatic disease (IRD) have isolated themselves. The lack of disease management together with fear of infection could lead to changes in physical- and mental health. The aim of this study was to evaluate the social- and health behaviour in patients with an IRD compared with the behaviour of healthy individuals during the COVID-19 pandemic. The study was a questionnaire survey answered by patients with an IRD and healthy individuals (HI). The questionnaire contained seven sections with questions regarding COVID-19 and quality of life including SF-36, EQ-5D-5L, and visual analogue scale (VAS) pain, fatigue and global health. Of 1663 invited participants, 661 patients with IRD and 266 HI were included in the analyses. Patients with an IRD felt more isolated during the COVID-19 pandemic compared with HI (IRD: 9.5% (61/644), HI: 3.1% (8/259), p-value = 0.001). More HI (5.4%) had been infected with COVID-19 than patients with an IRD (1.7%). Among patients with an IRD those with worse self-reported disease activity outcomes (VAS pain, fatigue and global health, all p-value < 0.001), worse social functioning and emotional well-being were more isolated than individuals with low disease activity. Patients with an IRD feel more isolated during the COVID-19 pandemic compared to HI. Isolation seems to be most pronounced in patients with worse disease related patient-reported outcomes and lower quality of life.
Literature
1.
go back to reference Cordtz R, Lindhardsen J, Soussi BG, Vela J, Uhrenholt L, Westermann R et al (2021) Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark. Rheumatology (Oxford) 60:59–67CrossRef Cordtz R, Lindhardsen J, Soussi BG, Vela J, Uhrenholt L, Westermann R et al (2021) Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark. Rheumatology (Oxford) 60:59–67CrossRef
2.
go back to reference Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52:53–61CrossRef Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52:53–61CrossRef
3.
go back to reference Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26:663–670CrossRefPubMed Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26:663–670CrossRefPubMed
4.
go back to reference Cordtz R, Kristensen S, Dalgaard LP, Westermann R, Duch K, Lindhardsen J et al (2021) Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark. J Clin Med 10:3842CrossRefPubMedPubMedCentral Cordtz R, Kristensen S, Dalgaard LP, Westermann R, Duch K, Lindhardsen J et al (2021) Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark. J Clin Med 10:3842CrossRefPubMedPubMedCentral
5.
go back to reference Glintborg B, Jensen DV, Engel S, Terslev L, Pfeiffer Jensen M, Hendricks O et al (2021) Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12,000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. RMD Open 7:e001505CrossRefPubMedPubMedCentral Glintborg B, Jensen DV, Engel S, Terslev L, Pfeiffer Jensen M, Hendricks O et al (2021) Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12,000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. RMD Open 7:e001505CrossRefPubMedPubMedCentral
6.
go back to reference Cleaton N, Raizada S, Barkham N, Venkatachalam S, Sheeran TP, Adizie T et al (2021) The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding. Rheumatol Int 41:707–714CrossRefPubMed Cleaton N, Raizada S, Barkham N, Venkatachalam S, Sheeran TP, Adizie T et al (2021) The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding. Rheumatol Int 41:707–714CrossRefPubMed
7.
go back to reference Eysenbach G (2004) Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 6:e34CrossRefPubMedPubMedCentral Eysenbach G (2004) Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 6:e34CrossRefPubMedPubMedCentral
8.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381CrossRefPubMed
9.
go back to reference Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208CrossRefPubMedPubMedCentral Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208CrossRefPubMedPubMedCentral
10.
go back to reference Chandran V, Bhella S, Schentag C, Gladman DD (2007) Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 66:936–939CrossRefPubMedPubMedCentral Chandran V, Bhella S, Schentag C, Gladman DD (2007) Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 66:936–939CrossRefPubMedPubMedCentral
11.
go back to reference Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811–819PubMed Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811–819PubMed
12.
go back to reference Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A (1997) Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 36:551–559CrossRefPubMed Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A (1997) Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 36:551–559CrossRefPubMed
13.
go back to reference Tsang HHL, Cheung JPY, Wong CKH, Cheung PWH, Lau CS, Chung HY (2019) Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis. Arthritis Res Ther 21:41CrossRefPubMedPubMedCentral Tsang HHL, Cheung JPY, Wong CKH, Cheung PWH, Lau CS, Chung HY (2019) Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis. Arthritis Res Ther 21:41CrossRefPubMedPubMedCentral
14.
go back to reference Van Tubergen A, Black PM, Coteur G (2015) Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis. Rheumatology 5:1842–1851CrossRef Van Tubergen A, Black PM, Coteur G (2015) Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis. Rheumatology 5:1842–1851CrossRef
15.
go back to reference Husted J, Gladman D, Farewell V, Long J, Cook R (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMed Husted J, Gladman D, Farewell V, Long J, Cook R (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMed
16.
go back to reference Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML (2008) Health-related quality of life: validity reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 35:1528–1537PubMed Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML (2008) Health-related quality of life: validity reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 35:1528–1537PubMed
17.
go back to reference Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP et al (2011) Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 38:898–903CrossRefPubMed Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP et al (2011) Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 38:898–903CrossRefPubMed
18.
go back to reference Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR et al (2020) Experiences of patients with rheumatic diseases in the United States during early days of the COVID-19 pandemic. ACR Open Rheumatol 2:335–343CrossRefPubMedPubMedCentral Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR et al (2020) Experiences of patients with rheumatic diseases in the United States during early days of the COVID-19 pandemic. ACR Open Rheumatol 2:335–343CrossRefPubMedPubMedCentral
Metadata
Title
Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey
Authors
Tobias Eschricht Eriksen
Wilfred K. H. Dinesen
Line Uhrenholt
Lene Dreyer
Kirsten Duch
Salome Kristensen
Publication date
01-05-2022
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 5/2022
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-022-05111-6

Other articles of this Issue 5/2022

Rheumatology International 5/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.